MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Operating Income 2011-2026 | CSII
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -35.8 M | -11.9 M | -26.8 M | -825 K | 2.23 M | -1.54 M | -56.1 M | -32.6 M | -33.5 M | -22.4 M | -14.5 M | -8.81 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.23 M | -56.1 M | -20.2 M |
Quarterly Operating Income Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.53 M | -10.9 M | -19.4 M | -9.65 M | -8.56 M | -8.12 M | -16.7 M | -5.65 M | 283 K | -1.66 M | 283 K | -2.74 M | -3.37 M | -5.93 M | -3.37 M | -5.93 M | 384 K | -2.97 M | 384 K | -2.97 M | -275 K | -1.75 M | -275 K | -1.75 M | 1.08 M | -1.87 M | 1.08 M | -1.87 M | -15.1 M | -13.2 M | -15.1 M | -13.2 M | -5.25 M | -8.19 M | -5.25 M | -8.19 M | -7.5 M | -6.85 M | -7.5 M | -6.85 M | -5.12 M | -5.21 M | -5.12 M | -5.21 M | -3.66 M | -3.1 M | -3.66 M | -3.1 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.08 M | -19.4 M | -5.57 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 4.3 | -0.69 % | $ 161 M |  France |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K |  USA |
 |
Axonics Modulation Technologies
AXNX
|
-26.1 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
-244 M | $ 2.29 | -2.97 % | $ 50.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.44 | -2.22 % | $ 324 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 8.27 | 0.49 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.01 | - | $ 17.1 M | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 73.83 | 0.26 % | $ 4.03 B |  Britain |
 |
LENSAR
LNSR
|
-24.6 M | $ 6.09 | 2.35 % | $ 72.8 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.46 | 0.17 % | $ 28.6 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 18.37 | -0.33 % | $ 431 M | USA |
 |
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.55 | 0.65 % | $ 63.1 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 11.02 | -3.76 % | $ 395 M | USA |
 |
MiMedx Group
MDXG
|
63.9 M | $ 3.62 | 0.28 % | $ 535 M | USA |
 |
Myomo
MYO
|
-14.4 M | $ 1.04 | 9.47 % | $ 43.5 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 10.75 | 3.27 % | $ 426 M |  Curacao |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
9.66 M | $ 38.22 | -0.93 % | $ 323 M | USA |
 |
Butterfly Network
BFLY
|
-86.4 M | $ 4.47 | -0.22 % | $ 1.1 B | USA |
 |
Profound Medical Corp.
PROF
|
-41.3 M | $ 6.83 | -2.01 % | $ 206 M | Canada |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 84.81 | 0.24 % | $ 11.5 B | USA |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.39 | 3.91 % | $ 6.63 M | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 154.87 | -1.29 % | $ 10.9 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 37.23 | 0.57 % | $ 1.16 B | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 43.84 | -2.01 % | $ 1.29 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 89.28 | -0.8 % | $ 3.1 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 85.78 | 3.1 % | $ 50.2 B | USA |
 |
TransMedics Group
TMDX
|
109 M | $ 68.94 | 0.12 % | $ 2.34 B | USA |